Myth-busting long-acting reversible contraceptives

Thomas Crow

writer

Thomas Crow

Claim CPD for this activity

Educational Activities (EA)

0 hours

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

Reviewing Performance (RP)

0 hours

These are activities that require reflection on feedback about your work.

Measuring Outcomes (MO)

0 hours

These are activities that use your work data to ensure quality results.

EA
0 minutes

These are activities that expand general practice knowledge, skills and attitudes, related to your scope of practice.

RP
0 minutes

These are activities that require reflection on feedback about your work.

MO
0 minutes

These are activities that use your work data to ensure quality results.

Thomas Crow

 
Every GP clinic should have at least one doctor who can insert an IUD or have a clear referral pathway, says Professor Deborah Bateson.

Long-acting reversible contraceptives (LARCs) remain an uncommon choice for Australian women, despite higher efficacy than condoms and the pill. Perceptions of painful insertions, outdated information and a lack of training are slowing adoption, but modern LARCs have a lot to offer.

Increasingly IUDs are being seen as a suitable, effective contraceptive option for a broader range of women. And, increasingly, women will be looking to their GP to have all the answers to questions about these devices, be it prior to insertion or once the device is in situ.

Professor Deborah Bateson and Dr Terri Foran, two experts in the field, will discuss common (and not-so-common) GP questions in a upcoming webcast on 27 September. Click here to register for this free webcast.

 

PASSWORD RESET

Forgot your password or password not working? Please enter your email address. You will receive an email with the link to set a new password.

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Fiona Chan

Dr Fiona Chan

Multiple Sclerosis vs Antibody Disease – What GPs Need to Know

Prof Andrew Sindone & Dr Ted Wu

Prof Andrew Sindone & Dr Ted Wu

Using SGLT2 to Reduce Cardiovascular Death in T2D – Important Updates for GPs

Prof Rod Baber

Prof Rod Baber

Menopause and MHT: Maximising Benefits & Minimising Risks

Dr Shannon Thomas

Dr Shannon Thomas

Peripheral Arterial Disease

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Share this

Share this

Thomas Crow

writer

Thomas Crow

Test your knowledge

Recent articles

Latest GP poll

Has a clinic you work at ever received an unfair negative online review?

Yes

0%

No

0%

Recent podcasts

Listen to expert interviews.
Click to open in a new tab

Find your area of interest

Once you confirm you’ve read this article you can complete a Patient Case Review to earn 0.5 hours CPD in the Reviewing Performance (RP) category.

Select ‘Confirm & learn‘ when you have read this article in its entirety and you will be taken to begin your Patient Case Review.

Menopause and MHT

Multiple sclerosis vs antibody disease

Using SGLT2 to reduce cardiovascular death in T2D

Peripheral arterial disease